Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete.

Gillen CM, Courtney HS, Schulze K, Rohde M, Wilson MR, Timmer AM, Guzman CA, Nizet V, Chhatwal GS, Walker MJ.

J Biol Chem. 2008 Mar 7;283(10):6359-66. doi: 10.1074/jbc.M706739200. Epub 2008 Jan 7.

PMID:
18180300
[PubMed - indexed for MEDLINE]
Free Article
2.

The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins.

Courtney HS, Pownall HJ.

J Biomed Biotechnol. 2010;2010:956071. doi: 10.1155/2010/956071. Epub 2010 Jul 8. Review.

PMID:
20671930
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Group A streptococcal antigens and vaccine potential.

Kehoe MA.

Vaccine. 1991 Nov;9(11):797-806. Review.

PMID:
1722063
[PubMed - indexed for MEDLINE]
4.

Lipid core peptide technology and group A streptococcal vaccine delivery.

Olive C, Batzloff MR, Toth I.

Expert Rev Vaccines. 2004 Feb;3(1):43-58. Review.

PMID:
14761243
[PubMed - indexed for MEDLINE]
5.

Current status of group A streptococcal vaccine development.

Dale JB.

Adv Exp Med Biol. 2008;609:53-63. doi: 10.1007/978-0-387-73960-1_5. Review.

PMID:
18193657
[PubMed - indexed for MEDLINE]
6.

Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.

Areschoug T, Carlsson F, Stålhammar-Carlemalm M, Lindahl G.

Vaccine. 2004 Dec 6;22 Suppl 1:S9-S14. Review.

PMID:
15576204
[PubMed - indexed for MEDLINE]
7.

Group A streptococcal vaccines: facts versus fantasy.

Steer AC, Batzloff MR, Mulholland K, Carapetis JR.

Curr Opin Infect Dis. 2009 Dec;22(6):544-52. doi: 10.1097/QCO.0b013e328332bbfe. Review.

PMID:
19797947
[PubMed - indexed for MEDLINE]
8.

Group A streptococcal adhesion. All of the theories are correct.

Hasty DL, Courtney HS.

Adv Exp Med Biol. 1996;408:81-94. Review. No abstract available.

PMID:
8895780
[PubMed - indexed for MEDLINE]
9.

A vaccine against Streptococcus pyogenes: the potential to prevent rheumatic fever and rheumatic heart disease.

Guilherme L, Ferreira FM, Köhler KF, Postol E, Kalil J.

Am J Cardiovasc Drugs. 2013 Feb;13(1):1-4. doi: 10.1007/s40256-013-0005-8. Review.

PMID:
23355360
[PubMed - indexed for MEDLINE]
10.

Towards a vaccine against rheumatic fever.

Guilherme L, Faé KC, Higa F, Chaves L, Oshiro SE, Freschi de Barros S, Puschel C, Juliano MA, Tanaka AC, Spina G, Kalil J.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):125-32. Review.

PMID:
17162355
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Novel strategies for controlling Streptococcus pyogenes infection and associated diseases: from potential peptide vaccines to antibody immunotherapy.

Pandey M, Sekuloski S, Batzloff MR.

Immunol Cell Biol. 2009 Jul;87(5):391-9. doi: 10.1038/icb.2009.29. Epub 2009 May 5. Review.

PMID:
19417770
[PubMed - indexed for MEDLINE]
12.

The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Dmitriev AV, Chaussee MS.

Future Microbiol. 2010 Oct;5(10):1539-51. doi: 10.2217/fmb.10.116. Review.

PMID:
21073313
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prospects for a group A streptococcal vaccine.

McMillan DJ, Chhatwal GS.

Curr Opin Mol Ther. 2005 Feb;7(1):11-6. Review.

PMID:
15732524
[PubMed - indexed for MEDLINE]
14.

Vaccine development for group A streptococcus infections and associated disease.

Batzloff MR, Sriprakash KS, Good MF.

Curr Drug Targets. 2004 Jan;5(1):57-69. Review.

PMID:
14738218
[PubMed - indexed for MEDLINE]
15.

Moving forward: a mucosal vaccine against group A streptococcus.

Georgousakis MM, McMillan DJ, Batzloff MR, Sriprakash KS.

Expert Rev Vaccines. 2009 Jun;8(6):747-60. doi: 10.1586/erv.09.33. Review.

PMID:
19485755
[PubMed - indexed for MEDLINE]
16.

Vaccinia virus: a novel approach for molecular engineering of peptide vaccines.

Hruby DE.

Semin Hematol. 1993 Oct;30(4 Suppl 4):35-43; discussion 44. Review.

PMID:
8303309
[PubMed - indexed for MEDLINE]
17.

Group A streptococcal vaccines.

Dale JB.

Infect Dis Clin North Am. 1999 Mar;13(1):227-43, viii. Review.

PMID:
10198801
[PubMed - indexed for MEDLINE]
18.

[Persistence of Streptococcus pyogenes].

Dmitrieva NF, Timofeev IuM, Briko NI.

Zh Mikrobiol Epidemiol Immunobiol. 2009 May-Jun;(3):104-9. Review. Russian.

PMID:
19621829
[PubMed - indexed for MEDLINE]
19.

Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

Olive C, Moyle PM, Toth I.

Curr Med Chem. 2007;14(28):2976-88. Review.

PMID:
18220734
[PubMed - indexed for MEDLINE]
20.

Group a streptococcal vaccine candidates: potential for the development of a human vaccine.

Henningham A, Gillen CM, Walker MJ.

Curr Top Microbiol Immunol. 2013;368:207-42. doi: 10.1007/82_2012_284. Review.

PMID:
23250780
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk